Literature DB >> 7802082

Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis.

L C Castro1, C J Hobel, J Gornbein.   

Abstract

OBJECTIVE: Our goals were (1) to use meta-analysis to determine whether pregnancy and the puerperium are accompanied by alterations in plasma atrial natriuretic peptide levels when compared with the nonpregnant state and (2) to evaluate the additional effects of hypertensive disease during pregnancy on plasma atrial natriuretic peptide levels. STUDY
DESIGN: Articles measuring atrial natriuretic peptide levels during pregnancy were reviewed. Data from articles meeting inclusion criteria were abstracted, and a meta-analysis was performed with the use of the maximum likelihood methods of Jennrich and Schluchter (Biometrics 1986;42:805-20).
RESULTS: The mean atrial natriuretic peptide level in nonpregnant control subjects was 28.7 pg/ml (95% confidence interval 22.5 to 36.7). The mean plasma atrial natriuretic peptide level rose 41% to 40.5 pg/ml (95% confidence interval 31.7 to 51.8) in the third trimester (p < 0.0001). It was 71.1 pg/ml (95% confidence interval 51.2 to 98.7) or 148% greater than the mean nonpregnant level during the first week post partum (p < 0.0001). Compared with levels in pregnant control subjects, plasma atrial natriuretic peptide levels increased 52% to 52.1 pg/ml (95% confidence interval 32.9 to 82.5) in women with gestational hypertension (p < 0.005) and 130% to 78.8 pg/ml (95% confidence interval 52.3 to 118.8) in women with preeclampsia (p < 0.0001). Chronic hypertension did not significantly alter atrial natriuretic peptide levels.
CONCLUSIONS: The 41% increase in atrial natriuretic peptide levels in the third trimester suggests that atrial stretch receptors sense the expanded blood volume as normal to moderately increased. The rise in atrial natriuretic peptide during the first week post partum is consistent with known hemodynamic changes and suggests that atrial natriuretic peptide may be involved in the postpartum diuresis. The marked increase in plasma atrial natriuretic peptide levels observed in preeclampsia is not likely to result from elevated arterial pressures alone but may reflect underlying factors unique to this disease process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7802082     DOI: 10.1016/0002-9378(94)90416-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.

Authors:  W Yan; F Wu; J Morser; Q Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study.

Authors:  Rima D Yarlagadda; Jonas Johnson; Åse Vårtun; Kari Flo; Ganesh Acharya
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-05       Impact factor: 3.007

3.  Diuretics vs. placebo for postpartum blood pressure control in preeclampsia (DIUPRE): a randomized clinical trial.

Authors:  Telma Cursino; Leila Katz; Isabela Coutinho; Melania Amorim
Journal:  Reprod Health       Date:  2015-08-05       Impact factor: 3.223

4.  Clonidine versus captopril for treatment of postpartum very high blood pressure: study protocol for a randomized controlled trial (CLONCAP).

Authors:  Carlos Noronha-Neto; Leila Katz; Isabela C Coutinho; Sabina B Maia; Alex Sandro Rolland Souza; Melania Maria Ramos Amorim
Journal:  Reprod Health       Date:  2013-07-30       Impact factor: 3.223

Review 5.  Physiological changes in pregnancy.

Authors:  Priya Soma-Pillay; Catherine Nelson-Piercy; Heli Tolppanen; Alexandre Mebazaa
Journal:  Cardiovasc J Afr       Date:  2016 Mar-Apr       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.